Comparison of Men's Prevention Apps to Research Efficacy (COMPARE)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33606
- University of South Florida, Infectious Diseases
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Prism Health
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Ayar @ Core
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Fenway Health Center
-
-
New York
-
Bronx, New York, United States, 10467
- Montefiore Children's Hospital
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28202
- RAIN, Inc
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Adolescent Initiative at Children's Hospital of Philadelphia
-
-
Texas
-
Houston, Texas, United States, 77030
- Baylor College of Medicine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 15 to 29 years.
- Assigned male sex at birth and male identified.
- Self-report being HIV uninfected or HIV status-unknown at screening.
- Self-report having not had an HIV test in the past 3 months.
- Self-report not currently taking PrEP.
- Self-report at least one episode of anal intercourse with a male or transfemale partner during the last 12 months.
- Able to understand, read, and speak English.
- Owns or leases a phone with Android platform or iOS platform, has an active data plan Has phone setting in English or Spanish, or willing to use an English or Spanish phone setting over the course of the study (Spanish setting is only for bilingual participants who speak both English and Spanish fluently)
- Willing and able to attend an in-person baseline study visit in one of the study site areas, or willing to attend a remote online baseline study visit
Exclusion Criteria:
- Currently enrolled in another HIV intervention study.
- Prior enrollment in an HIV vaccine trial with receipt of experimental vaccine product.
- Enrollment in Aims 2 and 3 of the prior MyChoices (UNC IRB# 17-0256) or LYNX (UNC IRB# 17-0170) studies
- Any medical, psychiatric, or social condition or other responsibilities that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
- Not willing and/or not able to download the MyChoices and LYNX apps onto their phone
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: LYNX
LYNX is developed using IMB model and engages youth through entering sexual diary data, earning badges, and calculating a personalized sexual protection (Sex Pro) score, which informs and motivates youth around HIV/STI testing and PrEP uptake.
Behavioral skills are built through HIV/STI testing reminders, presenting options for home HIV testing and/or linkage to nearby testing services, and access to an online chat with support for HIV/STI testing and PrEP referral.
|
Access to the LYNX mobile app which includes the Sex Pro score tool, sex diary, badges, PrEP information and video testimonials, HIV/STI testing reminders and geo-location features, and asynchronous chat feature.
|
|
EXPERIMENTAL: MyChoices
MyChoices is adapted from an app for adult MSM, HealthMindr, developed using SCT.
The app aims to increase HIV testing and PrEP uptake by increasing self- regulation, self-reflection, and self-efficacy around HIV testing and PrEP uptake.
Brief surveys about sexual risk and protective health behaviors within the app are used to assist users in tracking and self-monitoring their behaviors and creating a personalized HIV testing plan.
Quizzes, videos and infographics as well as "Help me Choose," "Ordering," and geofencing functions are used to maximize self-efficacy around HIV prevention and uptake of PrEP.
|
Access to the MyChoices mobile app which includes the HIV test plan with reminders, STI information, PrEP resources, links to testing and PrEP sites, and geo-location features.
|
|
NO_INTERVENTION: Standard of Care
Provision of referrals to local HIV/STI testing and PrEP resources.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Efficacy for HIV testing: Proportion who complete >= 1 HIV test
Time Frame: 6 months post baseline
|
Proportion who complete >= 1 HIV test
|
6 months post baseline
|
|
Efficacy for PrEP uptake: Proportion who uptake PrEP
Time Frame: 6 months post baseline
|
Proportion who uptake PrEP
|
6 months post baseline
|
|
Efficacy for STI testing: Proportion who complete >=1 STI test
Time Frame: 6 months post baseline
|
Proportion who complete >=1 STI test
|
6 months post baseline
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Efficacy for HIV testing: Proportion who complete >= 1 HIV test
Time Frame: 12 months post baseline
|
Proportion who complete >= 1 HIV test
|
12 months post baseline
|
|
Efficacy for PrEP uptake: Proportion who uptake PrEP
Time Frame: 12 months post baseline
|
Proportion who uptake PrEP
|
12 months post baseline
|
|
Efficacy for STI testing: Proportion who complete >=1 STI test
Time Frame: 12 months post baseline
|
Proportion who complete >=1 STI test
|
12 months post baseline
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Albert Y Liu, MD, MPH, San Francisco Department of Public Health
- Principal Investigator: Katie B Biello, PhD, MPH, Brown University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 19-0260
- 5U19HD089881 (NIH)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.